by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Shimoga Chemicals Warning Letter Details

Warning Letter

Shimoga Chemicals

W57A, MIDC, Kupwad Sangli 416436 Maharashtra India

Issue DateJuly 13, 2026

FEI Number3033881432

Violations3

CountryIndia

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

Shimoga Chemicals FDA Warning Letter, July 13, 2026